Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Moodys
Harvard Business School
McKinsey
Mallinckrodt

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Litigation Details for HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD. (D.N.J. 2011)


Email this page to a colleague

« Back to Dashboard

HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD. (D.N.J. 2011)

Docket ⤷  Try it Free Date Filed 2011-07-08
Court District Court, D. New Jersey Date Terminated 2015-11-15
Cause 35:145 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Douglas E. Arpert
Parties TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Patents 10,029,011; 10,086,005; 10,086,010; 10,114,012; 10,115,021; 10,174,017; 10,183,012; 6,063,802; 6,132,758; 6,168,016; 6,194,004; 6,284,770; 6,294,548; 7,157,017; 7,947,724; 7,947,725; 7,960,424; 8,044,014; 8,048,017; 8,063,015; 8,067,025; 8,114,021; 8,518,981; 8,598,218; 8,598,219; 9,022,022; 9,061,003; 9,061,005; 9,200,002
Attorneys MAYRA VELEZ TARANTINO
Firms Patunas Law LLC
Link to Docket External link to docket
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD.
Biologic Drugs cited in HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD.

Details for HELSINN HEALTHCARE S.A. v. DR. REDDY'S LABORATORIES, LTD. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2014-05-29 174 Dismissing with Prejudice United States Patent Nos. 8,518,981 and 8,598,218; setting schedule for the … infringement of United States Patent Nos. 8,.518,981, 8,598,218~ and 8,598,219 by Defendants…bench trial: U.S. Patent No. 7.947,724 claims 2 and 9, U.S. Patent No. 7,947,725 claim…claim 2, U.S. Patent No. 7,960,424 claim 6, and U.S. Patent No. 8.S98,219 olaims 1, …claims 2 and 9 of '724 patent, claim 2 of '725 patent, claims 2, 5, May 23,2014 External link to document
2014-06-19 176 (“the ‘724 patent”), 7,947,725 (“the ‘725 patent”), and 7,960,424 (“the ‘424 patent”) from the “first…Consolidation Order, this patent litigation now involves four asserted patents: U.S. Patent Nos. 7,947,724 (…ON THE ‘219 PATENT Like the asserted patents in the first action, the ‘219 patent discloses and…first” action, and U.S. Patent No. 8,598,219 (“the ‘219 patent”) from the “second” action (collectively…collectively, the “asserted patents”). The claims of the asserted patents are all directed to palonosetron External link to document
2014-06-20 178 (IT); Alberto 6,063,802 A 5/2000 Winterborn … 5,922,749, 5,622,720, 5,955,488, and 6,063,802. Coll1.1l1er- …claims of U.S. Patent Nos. 8,518,981 (the “’981 patent”); 8,598,218 (the “’218 patent”); and 8,598,219…claims of U.S. Patent Nos. 8,518,981 (the “’981 patent”); 8,598,218 (the “’218 patent”); and 8,598,219…United States Patent (10) Patent No.: External link to document
2014-10-06 220 80:8 47:14, 72:24, 73:10 86:10, 86:14, 89:12, 90:19, meet [6] - 13… 7 the '724 patent, '725 patent, the '424 patents in their 8 briefing…one today, the '219 patent in 13 red. All four of these patents are related. They…original 9 patents-in-suit, the '724, '725, and '424 patent they admit …them the family that led to this patent, 15 the '219 patent, and over and over again the patentees External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
AstraZeneca
McKesson
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.